Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Genentech
Genentech
Multiple Myeloma Research Foundation Bets on Adaptive Platform Clinical Trial Design
Xtalks
Mon, 12/10/18 - 07:07 pm
clinical trials
Multiple Myeloma
adaptive trial design
AbbVie
Celgene
Eli Lilly
Genentech
Janssen
Takeda
Genentech Scores FDA Approval for Tecentriq and Avastin Combo in NSCLC
BioSpace
Fri, 12/7/18 - 11:59 am
Genentech
FDA
Tecentriq
Avastin
non-squamous cell non-small cell lung cancer
Tecentriq could be first front-line SCLC therapy approved in two decades
BioCentury
Wed, 12/5/18 - 07:46 pm
FDA
Tecentriq
Genentech
extensive-stage small cell lung cancer
Roche Gains Place in NASH Race with Purchase of Jecure Therapeutics
Xconomy
Tue, 11/27/18 - 11:41 pm
Roche
Jecure Therapeutics
M&A
NASH
Genentech
FDA Approves Roche Subsidiary's Treatment for Acute Myeloid Leukemia
Yahoo/Guru Focus
Sat, 11/24/18 - 01:27 pm
Roche
Genentech
Venclexta
FDA
AML
acute myeloid leukemia
Drug Approvals for the 2 Most Common Types of Cancer in the Last 2 Years
BioSpace
Mon, 11/19/18 - 11:29 am
cancer
breast cancer
lung cancer
drug approvals
AstraZeneca
Takeda
Ariad Pharmaceuticals
Merck
Pfizer
Novartis
Boehringer Ingelheim
Bristol-Myers Squibb
Eli Lilly
Puma Biotechnology
Mylan
Genentech
Genentech to pay Immunocore $100M to co-develop preclinical MAGE-A4 drug
Fierce Biotech
Mon, 11/19/18 - 09:54 am
Genentech
Roche
MAGE-A4
IMC-C103C
Immunocore
Roche’s Tecentriq gets fast review in triple negative breast cancer
Pharmaforum
Tue, 11/13/18 - 09:51 am
Roche
Genentech
Tecentriq
Celgene
Abraxane
FDA
triple negative breast cancer
Genentech details claims Sanofi partner JHL used stolen trade secrets to develop rival drugs at an 'astonishing pace'
Endpoints
Fri, 11/9/18 - 12:15 pm
Genentech
Roche
JHL Biotech
trade secrets
Roche and AbbVie Push Towards First-Line CLL Treatment
BioSpace
Thu, 11/1/18 - 11:28 am
Roche
Genentech
AbbVie
clinical trials
Venclexta
Gazyva
CLL
chronic lymphocytic leukemia
Genentech staff ‘funneled secrets to Taiwan biosimilar firm,’ prosecutors say
Fierce Biotech
Tue, 10/30/18 - 06:59 pm
Genentech
trade secrets
Taiwan
biosimilars
Roche expands its PhIII program for Eylea rival as long-acting data back its blockbuster contender faricimab
Endpoints
Mon, 10/29/18 - 10:27 am
Roche
Genentech
Regeneron
Novartis
Eylea
faricimab
wet-AMD
Sanofi, Genentech Both Eye U.S. Expansions; Could Add up to 2,300 Jobs
BioSpace
Wed, 10/17/18 - 09:17 am
Sanofi
Cambridge MA
Genentech
Oregon
Roche and Novartis Strengthen Their Presence in the MS Market
BioSpace
Thu, 10/11/18 - 09:35 am
Genentech
Roche
Ocrevus
Novartis
siponimod
FDA
MS
multiple sclerosis
Two Genentech vets reunite at Immune-Onc to help steer its $33M drive to the clinic
Endpoints
Sat, 09/22/18 - 05:19 pm
Immune-Onc
Genentech
Genentech and Hemophilia Patients Eye Oct. 4 for Hemlibra Ruling
BioSpace
Tue, 09/18/18 - 10:14 pm
FDA
Genentech
Hemlibra
hemophilia
Roche's Child Arthritis Drug's New Formulation Gets FDA Nod
Yahoo/Zacks.com
Sat, 09/15/18 - 02:19 pm
Roche
Genentech
FDA
Actemra
systematic juvenile idiopathic arthritis
Roche CEO Severin Schwan is keeping his hand on the budget ax
Endpoints
Fri, 09/14/18 - 11:51 am
Roche
Genentech
Severin Schwan
R&D
layoffs
reorganization
New Flu Season, New Flu Drug from Genentech
BioSpace
Thu, 09/13/18 - 09:59 am
Genentech
balox
In a rare delay for the fast PD-1/L1 crowd, FDA tells Roche to wait on its Tecentriq/Avastin triple for lung cancer
Endpoints
Thu, 09/6/18 - 11:42 am
Genentech
Roch
Tecentriq
Avastin
lung cancer
FDA
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »